CN107094974A - 一种黑枸杞保健糖果及其制备方法 - Google Patents
一种黑枸杞保健糖果及其制备方法 Download PDFInfo
- Publication number
- CN107094974A CN107094974A CN201710548217.XA CN201710548217A CN107094974A CN 107094974 A CN107094974 A CN 107094974A CN 201710548217 A CN201710548217 A CN 201710548217A CN 107094974 A CN107094974 A CN 107094974A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- lycium ruthenicum
- health
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000169546 Lycium ruthenicum Species 0.000 title claims abstract description 54
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 172
- 235000013351 cheese Nutrition 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 28
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 24
- 235000020234 walnut Nutrition 0.000 claims abstract description 24
- 244000046101 Sophora japonica Species 0.000 claims abstract description 22
- 235000010586 Sophora japonica Nutrition 0.000 claims abstract description 22
- 235000013311 vegetables Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 229940067866 dandelion extract Drugs 0.000 claims abstract description 16
- 235000020691 dandelion extract Nutrition 0.000 claims abstract description 16
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims abstract description 16
- 235000011844 whole wheat flour Nutrition 0.000 claims abstract description 12
- SMHNUIFHMAGAFL-UHFFFAOYSA-N calcium;2-hydroxypropanoic acid Chemical compound [Ca].CC(O)C(O)=O SMHNUIFHMAGAFL-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 9
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 4
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 4
- 239000011710 vitamin D Substances 0.000 claims abstract description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 4
- 229940046008 vitamin d Drugs 0.000 claims abstract description 4
- 240000007049 Juglans regia Species 0.000 claims abstract 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 239000011782 vitamin Substances 0.000 claims description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 9
- 239000011435 rock Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 239000006188 syrup Substances 0.000 claims description 9
- 235000020357 syrup Nutrition 0.000 claims description 9
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 8
- 241000245665 Taraxacum Species 0.000 claims description 8
- 244000246386 Mentha pulegium Species 0.000 claims description 7
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 7
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 235000001050 hortel pimenta Nutrition 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 206010033546 Pallor Diseases 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 6
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 6
- 235000015165 citric acid Nutrition 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 235000019408 sucralose Nutrition 0.000 claims description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000000845 maltitol Substances 0.000 claims description 5
- 235000010449 maltitol Nutrition 0.000 claims description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 5
- 229940035436 maltitol Drugs 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 235000011475 lollipops Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 2
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 235000000832 Ayote Nutrition 0.000 claims description 2
- 240000006432 Carica papaya Species 0.000 claims description 2
- 235000009467 Carica papaya Nutrition 0.000 claims description 2
- 240000004244 Cucurbita moschata Species 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 2
- 244000300264 Spinacia oleracea Species 0.000 claims description 2
- 244000285940 beete Species 0.000 claims description 2
- 235000011222 chang cao shi Nutrition 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 235000015136 pumpkin Nutrition 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims 2
- 244000131522 Citrus pyriformis Species 0.000 claims 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- 240000007087 Apium graveolens Species 0.000 claims 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims 1
- 235000010591 Appio Nutrition 0.000 claims 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 244000228451 Stevia rebaudiana Species 0.000 claims 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims 1
- 239000001527 calcium lactate Substances 0.000 claims 1
- 229960002401 calcium lactate Drugs 0.000 claims 1
- 235000011086 calcium lactate Nutrition 0.000 claims 1
- 239000000686 essence Substances 0.000 claims 1
- 229930182478 glucoside Natural products 0.000 claims 1
- 150000008131 glucosides Chemical class 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 208000024891 symptom Diseases 0.000 abstract description 18
- 238000010521 absorption reaction Methods 0.000 abstract description 10
- 241000894006 Bacteria Species 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 230000003750 conditioning effect Effects 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000036407 pain Effects 0.000 abstract description 3
- 238000004891 communication Methods 0.000 abstract description 2
- 230000003467 diminishing effect Effects 0.000 abstract description 2
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 241000758789 Juglans Species 0.000 description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 15
- 229910052791 calcium Inorganic materials 0.000 description 15
- 239000011575 calcium Substances 0.000 description 15
- 235000001465 calcium Nutrition 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 241001247821 Ziziphus Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000009102 absorption Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 206010006326 Breath odour Diseases 0.000 description 7
- 208000032139 Halitosis Diseases 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 235000001055 magnesium Nutrition 0.000 description 6
- 229940091250 magnesium supplement Drugs 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 235000007686 potassium Nutrition 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 208000002399 aphthous stomatitis Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 208000020154 Acnes Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 239000004383 Steviol glycoside Substances 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229940108928 copper Drugs 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 206010039083 rhinitis Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 235000019411 steviol glycoside Nutrition 0.000 description 3
- 229930182488 steviol glycoside Natural products 0.000 description 3
- 150000008144 steviol glycosides Chemical class 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000186044 Actinomyces viscosus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 2
- 208000020670 canker sore Diseases 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- -1 oxygen radical Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical compound CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 235000000383 Juglans ailantifolia var cordiformis Nutrition 0.000 description 1
- 240000002220 Juglans microcarpa Species 0.000 description 1
- 235000000052 Juglans sieboldiana Nutrition 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101150042248 Mgmt gene Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000004855 amber Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000004888 little walnut Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 208000011479 upper respiratory tract disease Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/46—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing dairy products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种黑枸杞保健糖果及其制备方法，其特征在于由以下原料制成：黑枸杞粉、槐花米粉末、蒲公英提取物、全麦谷粉、乳酸钙粉、核桃粉、奶酪粉，维生素D、蔬菜粉、水果粉、乌梅粉、大枣粉、薄荷粉、甜味剂、辅料。本发明的保健糖果组方合理，配伍精良，兼顾体内组织和系统的调理、人体营养物质的补充和抑菌消炎促修复作用，尤其对因人体抵抗力底下、内热、内湿造成的红、肿、热、痛、烦等症状有防治功效；利用超微粉碎技术，防止了高温对有效物质的破坏获得了较高的有效成分，并更有利于人体吸收；同时携带方便，方便直接服用。
Description
技术领域
本发明涉及食品、保健品以及制备领域，尤其涉及一种以黑枸杞为主要原料制成的黑枸杞保健糖果及其制备方法。
背景技术
由于经济的日益发达，随着人们生活水平的不断提高，人们更加注重日常生活的保健。但是在生活工作压力下，健康情况却每况愈下，出现亚健康问题。人们过多的热爱享受，不注意自己的生活方式、行为习惯、饮食嗜好，养成不良的生活习惯，加之生活环境的恶化，从而引起各种疾病。生活饮食过于精细，运动量减少，或暴饮暴食，或劳倦过度，使得人体代谢机能逐渐衰退，导致脏腑功能失调。出现人体很多红、肿、热、痛、烦等具体表现。
现在，我们身体过多地承受了来自食品、饮用水、空气和动植物(如花粉)的化学物质及污染物，伴随生活工作的压力，其结果，出现更多诸如心神不安、惊悸少眠、头胀头疼、眼睛疲劳、倦怠无力、易怒、记忆力不好等各种亚健康症状。生活不规律，暴饮暴食，极易导致抵抗力底下，上火，出现口腔溃疡、牙龈肿痛、咳嗽、黄痰、口臭、鼻炎、咽炎、上呼吸道疾病，便成了非常普遍的疾病，给日常生活带来极大的困扰。更严重的甚至会导致发展为体内各种炎症。
传统的糖果食品一般只能满足人们补充营养以及食物多样化方面的需求，通常只注重色香味等方面的需求。营养性压片糖果既可以充当食品，又含有功能性组分，起到调节身体、有助健康的作用，广受现代人们的喜爱。
发明内容
本发明的目的是提供一种黑枸杞保健糖果糖果。
本发明的技术方案如下：
所述的黑枸杞保健糖果糖果由以下组分制成：黑枸杞粉、槐花米粉末、蒲公英提取物、全麦谷粉、乳酸钙粉、核桃粉、奶酪粉，维生素D、蔬菜粉、水果粉、乌梅粉、大枣粉、薄荷粉、甜味剂、辅料。
优选的，所述的蔬菜粉包括芹菜粉、菠菜粉、紫菜粉、南瓜粉、黑木粉、胡萝卜粉中的一种或多种；所述的水果粉包括香蕉粉、菠萝粉、苹果粉、猕猴桃粉、木瓜粉中的一种或多种。
优选的，甜味剂选自下列的一种或几种：冰糖、麦芽糖醇、山梨糖醇、木糖醇、异麦芽酮糖醇、帕拉金糖、阿斯巴甜、甜菊糖苷。
优选的，括麦芽糊精、微晶纤维素、柠檬酸、三氯蔗糖、硬脂酸镁。
优选的，黑枸杞保健糖果由以下重量份数的原料制备而成：黑枸杞粉20-50份、槐花米粉末20-30份、蒲公英提取物10-20份、全麦谷粉10-30份、乳酸钙粉10-25份、核桃粉10-25份、奶酪粉10-20份，维生素D10-20份、蔬菜粉10-20份、水果粉10-20份、乌梅粉5-10份、大枣粉5-20份、薄荷粉5-10份、甜味剂15-25份，辅料20-40份。
优选的，黑枸杞保健糖果由以下重量份数的原料制备而成：黑枸杞粉25-35份、槐花米15-25份、蒲公英提取物13-18份、全麦谷粉15-25份、乳酸钙粉15-23份、核桃粉15-23份、奶酪粉13-18份，维生素D15-18份、蔬菜粉12-16份、水果粉12-16份、乌梅粉6-8份、大枣粉10-15份、薄荷粉6-8份、甜味剂16-20份、辅料25-38份。
优选的，黑枸杞保健糖果由以下重量份数的原料制备而成：黑枸杞粉25份、槐花米23份、蒲公英提取物15份、全麦谷粉18份、乳酸钙粉16份、核桃粉18份、奶酪粉16份，维生素D17份、蔬菜粉15份、水果粉15份、乌梅粉7份、大枣粉14份、薄荷粉7份、冰糖4份、麦芽糖醇4份、木糖醇4份、麦芽糊精12份、微晶纤维素15份、柠檬酸3份、三氯蔗糖3份、硬脂酸镁2份。
本发明还提供了黑枸杞保健糖果的制备方法包括以下步骤：
a、分别将黑枸杞干果、槐花米、核桃、乌梅、乳酪、薄荷、选用的蔬菜和水果经温度-40至-80℃，冻干压力20Pa至50Pa，冷冻干燥10至15h，后置于低温超微粉碎机中粉碎，粉碎温度为-10℃～-20℃，过100目筛，微波灭菌5分钟，制得黑枸杞粉、槐花米粉末、核桃粉、乌梅粉、乳酪粉、薄荷粉、蔬菜粉和水果粉；
b、制备蒲公英提取物，将蒲公英全草洗净，在90-95℃热水中热烫25-35s，热烫结束后迅速放于5-10℃的冷水中，浸泡1-2分钟，取出后在1000±100r/min的转速下，进行榨汁，过滤取汁，浓缩，在68-72℃的条件下加热杀菌3-5分钟，35℃真空干燥后，得蒲公英提取物，水分含量小于5％；
c、将各种原料按照重量份数称好后，均匀混合，得混合原料备用；
d、将步骤c的混合原料中加入均质机均质后，用27％-50％(m/v)的食用酒精，搅拌制软剂、过20目筛，得半固体颗粒；
e、将步骤d的半固体颗粒至于烘箱中烘干，并控制烘箱温度37℃-45℃，干燥4-6h后得到干颗粒；
f、将步骤e的干颗粒通过压片机进行压片处理，压力40-60kN，得到压片糖果。
所述的一种黑枸杞保健糖果的制备方法，其中，步骤f中，控制压片处理时的压力30-45kN可以制得咀嚼糖果。
所述的一种黑枸杞保健糖果的制备方法，其中，步骤e中将各种原料按照重量份数称好后，备用，将冰糖及选用的其他甜味剂和水按10:1的质量比，加热熬制30-45分钟，熬制糖浆。再将各种原料按照重量份数称好后，均匀混合的混合原料加入糖浆中，搅拌均匀，得棒棒糖浆；注入模具中，然后-10-15℃冷却脱模制得棒棒糖。
本发明所采用的功效成分有黑枸杞粉、槐花米粉末、蒲公英提取物、全麦谷粉、乳酸钙粉、核桃粉、奶酪粉，维生素D、蔬菜粉、水果粉、乌梅粉、大枣粉、奶酪粉、薄荷粉。
黑枸杞，又名黑果枸杞，属于茄科枸杞属，黑枸杞含有17种氨基酸，13种微量元素，含量排名前五位的是Fe402.6mg/kg、Ca4972.06mg/kg、K1669.58mg/kg、Na2162.29mg/kg、Mg1926.31mg/kg、Zn28.30mg/kg，Mn13.27、Cu13.54、，其中钙、镁、锌、铁的含量也高于红枸杞。黑枸杞味甘、性平，含有丰富的蛋白质、矿物质、微量元素、生物碱、VC、B1、B2、钙、镁、铜、锌、锰、铁、铅、镍、镉、钴、铬、钾、钠等各种营养成分。黑枸杞鲜果经研究测试含油率达到5.54％，总糖的含量为6.9％，总酸的含量为0.73％，维生素C含量为3.02mg/100g，维生素B1含量为0.07mg/100g，维生素B2含量为0.02mg/100g，总花色苷的含量达386.9mg/100g。本发明所采用的黑枸杞为市售青海格尔木种植枸杞。
黑枸杞粉中富含的原花青素，具有抗过敏抗炎症的功效。有助于治疗过敏、气喘、支气管炎、花粉热、类风湿动脉炎、运动受伤、溃疡等疾病。人体发炎时要释放出一种名叫组胺的化合物，它可诱发上述疾病的种种症状。原花青素抑制产生组胺需要的酶，防止生成组胺，从而减轻发炎。原花青素是组胺的著名的抑制剂，但它并不阻碍其它的酶。
蒲公英富含维生素A、维生素C及钾，也含有铁、钙、维生素B2、维生素B1、镁、维生素B6、叶酸及铜。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分。性味甘，微苦，寒。归肝、胃经。具有清热解毒的功效，有调理肝火、肺火、胃火的功效。尤善清肝热，治疗肝热目赤肿痛，口舌生疮、热毒疮疡；有治湿热、黄疸之功效；有利尿、缓泻、退黄疸、利胆等功效；具有抗真菌杀菌功效；能通过免疫机制起到抗肿瘤作用；治急性乳腺炎，淋巴腺炎，疔毒疮肿，急性结膜炎，感冒发热，急性扁桃体炎，急性支气管炎，胃炎，肝炎，胆囊炎，尿路感染等。富含维生素A、C及矿物质，对消化不良、便秘有改善作用，对保护皮肤，防治雀斑、粉刺面疮有功效。蒲公英是药食兼用的植物。
槐花米系豆科植物，凉血止血，并有清肝泻火、治疗肝热目赤、头痛眩晕的作用。槐花米中含有芦丁和槲皮素成分，具有抗炎作用，维持血管抵抗力，降低通透性，减少脆性作用本品所含的槲皮素有一定的平喘作用。此外还有降低血压，增强毛细血管抵抗力，减少毛细血管脆性、降血脂，扩张冠状动脉，增加冠脉血流量等作用。槐花米中含蛋白质、氨基酸、黄酮和硒，嘴烂、烫伤、软组织受伤等症状有加快愈合的功效；同时增加抵抗力、帮助消化吸收，对损伤的胃粘膜修复再生，对消化系统一些列炎症所导致的疾病有显著的治疗作用；硒的抗氧化作用是VC和VE的300-500倍，具有极强的清除体内氧自由基的能力，清除体内毒素加强新陈代谢，调理内分泌平衡，提高免疫力，同时具有滋养皮肤、美白减皱的效果。
核桃含有丰富的不饱脂肪酸，经常食用核桃，不但不会升高血糖，还能减少肠道对胆固醇的吸收，核桃含有大量的脂肪，能润肠，治疗大便秘结。核桃含有丰富的维生素B族和维生素E，可使细胞免受自由基的氧化损害，有健脑，增强记忆力和延缓衰老的作用，是医学界公认的抗衰老物质。核桃仁含有亚麻油酸及钙、磷、铁，是人体理想的肌肤美容剂，经常食用有润肌肤、乌须发，及具有防治头发过早变白和脱落的功能。还能治疗神经衰弱的辅助剂，能延缓记忆力衰退。核桃仁还含有多种人体需要的微量元素，是中成药的重要辅料，有顺气补血，止咳化痰，润肺补肾等功能。当感到疲劳时，嚼些核桃仁，有缓解疲劳和压力。
奶酪是一种公认的营养佳品，因此又被称为“奶黄金”。制作1kg的奶酪大约需要10kg的牛奶。奶酪中除含有优质蛋白质外，奶酪还有糖类、有机酸、钙、磷、钠、钾、镁等微量矿物元素，铁、锌以及脂溶性维生素A，胡萝卜素和水溶性的维生素B1、B2、B6、B12、烟酸、泛酸、生物素等多种营养成分，这些物质具有许多重要的生理功能。钙摄取不足会动摇骨本，所以每天要从各种天然食物里补充钙。奶酪不但是钙的良好来源之一，它对牙齿还能发挥其他保护作用。除了丰富的钙、磷等牙齿营养物质，奶酪还含有独特的酪蛋白，酪蛋白能有效阻止牙菌斑形成，修复牙齿的损伤。此外，奶酪还可以刺激唾液的分泌，中和平衡口腔内的酸性环境，抑制细菌生长，坚固牙胚，对口腔保健具有功效。
乌梅是蔷薇科落叶乔木植物梅的没有成熟的果实，其中含有柠檬酸、苹果酸、琥珀酸、糖类、谷甾醇、维生素C等成份，具有非常理想的抗菌的作用。
薄荷是中国常用中药，幼嫩茎尖可作菜食，全草又可入药，治感冒发热喉痛，头痛，目赤痛，肌肉疼痛，皮肤风疹搔痒，麻疹不透等症，此外对痈、疽、疥、癣、漆疮亦有效。薄荷含有薄荷醇，该物质可清新口气并具有多种药性，具有防腐杀菌、利尿、化痰、健胃和助消化等功效。小剂量食用却有助于睡眠。
大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分中医中药理论认为，红枣具有补虚益气、养血安神、健脾和胃等作用，是脾胃虚弱、气血不足、倦怠无力、失眠多梦等患者良好的保健营养品果。大枣补中益气，养血安神。用于脾虚食少，乏力便溏，妇人脏躁。能行气，活血，调经，是补血佳品。
低温粉碎机：又名超微粉碎机，以液氮为冷冻剂，将被粉碎的物料降至玻璃化温度，利用物质在低温下变脆的性质。可进行高温、常温、低温或超低温的微粉碎，可以保持物料的原有理化性质和活性成份。给磨筒外壁的夹套通入冷水。通过调节冷却水的温度和流量可控制粉碎温度。低温粉碎，冷冻系统最低温度可达零下35℃。本专利采用的低温超微粉碎机是山东建辰机械有限公司生产，型号为JFM-6J。
本发明的配方原料甄选，充分考量各种成分中的营养素。考虑各种营养物质的均衡和协同作用，该成分组合协同黑枸杞、蒲公英、大枣对体内组织和系统的调理，同时选用槐花米、乌梅、薄荷等安全可食用的杀菌、消炎、促修复成分，并且兼顾各种营养素互相补充促进人体对钙磷铁及维生素等的吸收。黑枸杞的人体吸收和功效也得到了提升。
黑枸杞中微量元素铁、钙、镁、锌、钾的含量很高，并且富含的赖氨酸精氨酸促进人体对钙质的吸收。其中钾的摄入可降低尿钙的排除，并增加钙的重吸收，进而提高骨密度。同时VD的加入又促进钙磷的吸收防止骨质疏松。添加奶酪粉，富含乳酸菌和钙质，有助于人体对钙磷的吸收，增加钾、镁、锌、铜的摄入。本发明所提供的原料配比中，黑枸杞和大枣中富含铁元素，VC可促进人体对铁的吸收。各项营养素之间互相协同作用，更有助于人体的吸收。VE为脂溶性营养素，配方中添加核桃粉其脂肪含量有助于VE的吸收。
本发明的有益效果为：组方合理，配伍精良，兼顾体内组织和系统的调理、人体营养物质的补充和抑菌消炎促修复作用。尤其对因人体抵抗力底下、内热、内湿造成的红、肿、热、痛、烦等症状有防止功效。具体表现为口舌生疮、咽干目涩、牙龈肿痛、面部痤疮、溃疡、咳嗽、黄痰、口臭、鼻炎、咽炎、上呼吸道不适等症。利用超微粉碎技术，防止了高温对有效物质的破坏获得了较高的有效成分，并更有利于人体吸收。省去了熬制加工的麻烦，同时携带方便，方便直接服用。
具体实施方案
实施例1：
分别将黑枸杞干果、乌梅、乳酪、薄荷、选用的蔬菜和水果经温度-40至-80℃，冻干压力20Pa至50Pa，冷冻干燥10至15h，后置于低温超微粉碎机中粉碎，粉碎温度为-10℃～-20℃，过100目筛，微波灭菌5分钟，制得黑枸杞粉、乌梅粉、乳酪粉、薄荷粉、蔬菜粉和水果粉；
分别将槐花米和核桃粉碎，过100目筛，微波灭菌5分钟；
蒲公英提取物的制备，经蒲公英全草洗净，在90-95℃热水中热烫25-35s，热烫结束后迅速放于5-10℃的冷水中，浸泡1-2分钟，取出后在1000±100r/min的转速下，进行榨汁，过滤取汁，浓缩，在68-72℃的条件下加热杀菌3-5分钟，35℃真空干燥后，得蒲公英提取物，水分含量小于5％。
按照重量份数的原料称取：黑枸杞粉25份、槐花米23份、蒲公英提取物15份、全麦谷粉18份、乳酸钙粉16份、核桃粉18份、奶酪粉16份，维生素D17份、蔬菜粉15份、水果粉15份、乌梅粉7份、大枣粉14份、薄荷粉7份、冰糖4份、麦芽糖醇4份、木糖醇4份。
将称好的各种原料，加入麦芽糊精20份、微晶纤维素16份、柠檬酸2份、三氯蔗糖3份、硬脂酸镁2份，充分混合、均质、加入27％(m/v)的食用酒精，过20目筛；将所得半固体颗粒至于烘箱中烘干，并控制烘箱温度37℃-45℃，干燥4-6h后得到干颗粒。
将干颗粒通过五冲头的压片机(ZP-5冲旋转式)进行压片处理(压力40-60kN)，得到压片糖果。
实施例2：
按照重量份数称取：黑枸杞粉31份、槐花米18份、蒲公英提取物13份、全麦谷粉25份、乳酸钙粉23份、核桃粉15份、奶酪粉17份，维生素D15份、蔬菜粉12份、水果粉16份、乌梅粉6份、大枣粉15份、薄荷粉8份、山梨糖醇10份、阿斯巴甜7份。麦芽糊精12份、微晶纤维素15份、柠檬酸3份、三氯蔗糖3份、硬脂酸镁2份。
将称好的各种原料，充分混合、均质、加入27％(m/v)的食用酒精，过20目筛；将所得半固体颗粒至于烘箱中烘干，并控制烘箱温度37℃-45℃，干燥4-6h后得到干颗粒。
将干颗粒通过五冲头的压片机(ZP-5冲旋转式)进行压片处理，,压力30-45kN，得到咀嚼糖果。
实施例3：
按照重量份数称取黑枸杞粉25份、槐花米25份、蒲公英提取物15份、全麦谷粉22份、乳酸钙粉18份、核桃粉23份、奶酪粉13份，维生素D17份、蔬菜粉16份、水果粉12份、乌梅粉8份、大枣粉10份、薄荷粉8份、冰糖10份、甜菊糖苷10份。
将原料按比例称量好后，混合均匀，备用。
将冰糖10份、甜菊糖苷10份混合后与水按照质量部1:10的比例混合，加热30-40分钟，熬制糖浆。将糖浆倒入混合均匀的原料中，搅拌20-25分钟，得棒棒糖浆。将棒棒糖浆倒入模具中，放上小棒，置于-10至-15℃冷却18分钟，脱模制得棒棒糖。
1、抑菌试验
将糖果粉碎，在锅中加入5倍量的水，熬煮，至水分含量为糖果重量的1倍，离心分离20分钟，取汤液，分别取100微升汤液加入变形链球菌、梭形杆菌和粘性放线菌的培养皿中，进行抑菌试验，培养12-14小时，利用游标卡尺测量抑菌圈的直径大小，实施例糖果的抑制口腔细菌的效果如下：
2、试服功效验证
2.1试肤方法
治疗组服用本发明制备的黑枸杞糖果，每次一片，10g，一天二次，疗程6个月。360名有上火症状患者，年龄30-50岁，分3个治疗组，每组120人分别服用实施例1-3的产品。效果对比试验如下表。
2.2疗效评价标准
口舌生疮、目赤干涩、牙龈肿痛、面部痤疮、溃疡、咳嗽、黄痰、口臭、鼻炎、咽炎、上呼吸道不适等症。分三级进行判定：
显效：症状好转效果明显；
有效：症状好转或略有效果；
无效：症状无改变或减轻不明显。
总有效率＝(显效+有效)/总病例数×100％
2.3治疗结果
治疗结果如下表所示
患者A，女，45岁，主要症状牙龈肿痛，出血。自开始服用实施例1中的糖果，每日二次，每次一颗，10g/片，连续服用5天后，感觉牙龈肿痛症状消失，牙龈不再出血。经常食用，牙龈肿痛和出血症状未见复发。
患者B，男，35岁，长期口腔溃疡。服用实施例1中的糖果，每日二次，每次一颗，10g/片，服用6天后，溃疡消失，继续服用30天，为再长口腔溃疡。
患者C，女，46岁，患有咽炎，主要症状为咽痛，痰盛，有异物感，并且伴有咳嗽等现象。坚持服用实施例2的糖果产品半月后，咽痛减轻，咽喉清爽，症状缓解，后又继续服用1个月后，咽炎症状得到控制和改善。
患者D，男，36岁，经常目赤干涩，口臭，服用实施例2的咀嚼糖果3个月后，口臭症状减轻，目赤干涩症状彻底消失。后又继续服用3个月，口臭症状基本消失。
3、功效验证结果
本发明的糖果作用于变形链球菌、梭形杆菌和粘性放线菌的抑菌圈非常明显，抑菌效果明显，说明实施例的糖果有抑菌效果。
对有口舌生疮、目赤干涩、牙龈肿痛、面部痤疮、溃疡、口臭、上呼吸道不适症状的患者服用实施例的压片糖果、咀嚼糖果、棒棒糖半年后，防治有效率80％以上，对上述因体内热和湿导致的症状有治愈功效。
上述数据显示，本发明的黑枸杞糖果在防治和调理抵抗力底下，内热和内湿等亚健康症状有突出的效果。
上述实施例只是为了说明本发明的技术构思及特点，其目的是在于让本领域内的普通技术人员能够了解本发明的内容并据以实施，并不能以此限制本发明的保护范围。凡是根据本发明内容的实质所作出的等效的变化或修饰，都应涵盖在本发明的保护范围内。
Claims (10)
1.一种黑枸杞保健糖果，其特征在于，所述的糖果由以下组分制成：黑枸杞粉、槐花米粉末、蒲公英提取物、全麦谷粉、乳酸钙粉、核桃粉、奶酪粉，维生素D、蔬菜粉、水果粉、乌梅粉、大枣粉、薄荷粉、甜味剂、辅料。
2.根据权利要求1所述的一种黑枸杞保健糖果，其特征在于，所述的蔬菜粉包括芹菜粉、菠菜粉、紫菜粉、南瓜粉、黑木粉、胡萝卜粉中的一种或多种；所述的水果粉包括香蕉粉、菠萝粉、苹果粉、猕猴桃粉、木瓜粉中的一种或多种。
3.根据权利要求1所述的一种黑枸杞保健糖果，其特征在于，所述的甜味剂选自下列的一种或几种：冰糖、麦芽糖醇、山梨糖醇、木糖醇、异麦芽酮糖醇、帕拉金糖、阿斯巴甜、甜菊糖苷。
4.根据权利要求1所述的一种黑枸杞保健糖果，其特征在于，所述的辅料包括麦芽糊精、微晶纤维素、柠檬酸、三氯蔗糖、硬脂酸镁。
5.根据权利要求4所述的一种黑枸杞保健糖果，其特征在于，所述的糖果由以下重量份数的原料制备而成：黑枸杞粉20-50份、槐花米20-30份、蒲公英提取物10-20份、全麦谷粉10-30份、乳酸钙粉10-25份、核桃粉10-25份、奶酪粉10-20份，维生素D10-20份、蔬菜粉10-20份、水果粉10-20份、乌梅粉5-10份、大枣粉5-20份、薄荷粉5-10份、甜味剂15-25份、辅料20-40份。
6.根据权利要求5所述的一种黑枸杞保健糖果，其特征在于，所述的糖果由以下重量份数的原料制备而成：黑枸杞粉25-35份、槐花米15-25份、蒲公英提取物13-18份、全麦谷粉15-25份、乳酸钙粉15-23份、核桃粉15-23份、奶酪粉13-18份，维生素D15-18份、蔬菜粉12-16份、水果粉12-16份、乌梅粉6-8份、大枣粉10-15份、薄荷粉6-8份、甜味剂16-20份、辅料25-38份。
7.根据权利要求6所述的一种黑枸杞保健糖果，其特征在于，所述的糖果由以下重量份数的原料制备而成：黑枸杞粉25份、槐花米23份、蒲公英提取物15份、全麦谷粉18份、乳酸钙粉16份、核桃粉18份、奶酪粉16份，维生素D17份、蔬菜粉15份、水果粉15份、乌梅粉7份、大枣粉14份、薄荷粉7份、冰糖4份、麦芽糖醇4份、木糖醇4份、麦芽糊精12份、微晶纤维素15份、柠檬酸3份、三氯蔗糖3份、硬脂酸镁2份。
8.根据权利要求5-7中任意一项权利要求中所述的一种黑枸杞保健糖果的制备方法，其特征在于，包括以下步骤：
a、分别将黑枸杞干果、槐花米、核桃、乌梅、乳酪、薄荷、选用的蔬菜粉和水果粉经温度-40至-80℃，冻干压力20Pa至50Pa，冷冻干燥10至15h，后置于低温超微粉碎机中粉碎，粉碎温度为-10℃～-20℃，过100目筛，微波灭菌5分钟，制得黑枸杞粉、槐花米粉末、核桃粉、乌梅粉、乳酪粉、薄荷粉、蔬菜粉和水果粉；
b、制备蒲公英提取物，将蒲公英全草洗净，在90-95℃热水中热烫25-35s，热烫结束后迅速放于5-10℃的冷水中，浸泡1-2分钟，取出后在1000±100r/min的转速下，进行榨汁，过滤取汁，浓缩，在68-72℃的条件下加热杀菌3-5分钟，35℃真空干燥后，得蒲公英提取物，水分含量小于5%；
c、将各种原料按照重量份数称好后，均匀混合，得混合原料备用；
d、将步骤c的混合原料均质后，用27%-50%（m/v）的食用酒精，搅拌制软剂、过20目筛，得半固体颗粒；
e、将步骤d的半固体颗粒至于烘箱中烘干，并控制烘箱温度37℃-45℃，干燥4-6h后得到干颗粒；
f、将步骤e的干颗粒通过压片机进行压片处理，压力40-60kN，得到压片糖果。
9.根据权利要求是7所述的一种黑枸杞保健糖果的制备方法，其特征在于，其中f步骤中，控制压片处理时的压力30-45kN制得咀嚼糖果。
10.根据权利要求7所述的一种黑枸杞保健糖果的制备方法，其特征在于，步骤e将各种原料按照重量份数称好后备用，将冰糖及选用的其他甜味剂和水按10:1的质量比，加热熬制30-45分钟，熬制糖浆；再将各种原料按照重量份数称好后，均匀混合的混合原料加入糖浆中，搅拌均匀，得棒棒糖浆；注入模具中，然后-10-15℃冷却脱模制得棒棒糖。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710548217.XA CN107094974A (zh) | 2017-07-06 | 2017-07-06 | 一种黑枸杞保健糖果及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710548217.XA CN107094974A (zh) | 2017-07-06 | 2017-07-06 | 一种黑枸杞保健糖果及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107094974A true CN107094974A (zh) | 2017-08-29 |
Family
ID=59663669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710548217.XA Pending CN107094974A (zh) | 2017-07-06 | 2017-07-06 | 一种黑枸杞保健糖果及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107094974A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107495374A (zh) * | 2017-09-29 | 2017-12-22 | 杞源堂（宁夏）生物科技有限公司 | 一种含枸杞果粒的富硒西瓜粉口含片及其制备方法 |
| CN108391803A (zh) * | 2018-01-12 | 2018-08-14 | 杭州姚生记食品有限公司 | 一种山核桃仁水果粒复合食品及其制备方法 |
| CN109198143A (zh) * | 2018-08-13 | 2019-01-15 | 韩恩珍 | 具有预防和治疗癌症功效的超浓缩生物复合花青素压片糖果及制备方法 |
| CN109965070A (zh) * | 2017-12-27 | 2019-07-05 | 上海梓惜生物技术有限公司 | 一种枸杞蒲公英压片糖果及其制备方法 |
| CN111035007A (zh) * | 2018-10-11 | 2020-04-21 | 张秀成 | 补虚损保健品组合物及其制备方法和其应用 |
| CN115444063A (zh) * | 2022-08-26 | 2022-12-09 | 衡阳周福记食品有限公司 | 一种护齿棒棒糖的制备方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100793822B1 (ko) * | 2007-01-10 | 2008-01-10 | 함양군 | 생약재 추출물을 함유하는 캔디의 제조방법 |
| KR101458111B1 (ko) * | 2014-06-05 | 2014-11-05 | 농업회사법인 오르피아 주식회사 | 유기쌀 이소말토 올리고당 시럽을 주재료로 한 허브캔디의 제조방법 |
| CN104186886A (zh) * | 2014-05-30 | 2014-12-10 | 呼玛县天地山野产品有限责任公司 | 一种含有紫色山药的蓝莓压片糖及其制备方法 |
| KR20160009936A (ko) * | 2014-07-17 | 2016-01-27 | 한국식품연구원 | 구연산을 대체한 천연 첨가물을 포함하는 사탕 제조방법 |
| CN105412354A (zh) * | 2015-12-01 | 2016-03-23 | 苟春虎 | 黑枸杞护眼棒棒糖 |
| CN105795079A (zh) * | 2016-03-15 | 2016-07-27 | 周利 | 一种具备治疗口腔溃疡的硬质糖果及其制备方法 |
| CN106070972A (zh) * | 2016-06-14 | 2016-11-09 | 山东润美生物科技有限公司 | 黑枸杞压片糖果 |
| CN106306314A (zh) * | 2016-10-12 | 2017-01-11 | 肥西久盛食品有限公司 | 一种清咽润喉的魔芋花生糖 |
-
2017
- 2017-07-06 CN CN201710548217.XA patent/CN107094974A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100793822B1 (ko) * | 2007-01-10 | 2008-01-10 | 함양군 | 생약재 추출물을 함유하는 캔디의 제조방법 |
| CN104186886A (zh) * | 2014-05-30 | 2014-12-10 | 呼玛县天地山野产品有限责任公司 | 一种含有紫色山药的蓝莓压片糖及其制备方法 |
| KR101458111B1 (ko) * | 2014-06-05 | 2014-11-05 | 농업회사법인 오르피아 주식회사 | 유기쌀 이소말토 올리고당 시럽을 주재료로 한 허브캔디의 제조방법 |
| KR20160009936A (ko) * | 2014-07-17 | 2016-01-27 | 한국식품연구원 | 구연산을 대체한 천연 첨가물을 포함하는 사탕 제조방법 |
| CN105412354A (zh) * | 2015-12-01 | 2016-03-23 | 苟春虎 | 黑枸杞护眼棒棒糖 |
| CN105795079A (zh) * | 2016-03-15 | 2016-07-27 | 周利 | 一种具备治疗口腔溃疡的硬质糖果及其制备方法 |
| CN106070972A (zh) * | 2016-06-14 | 2016-11-09 | 山东润美生物科技有限公司 | 黑枸杞压片糖果 |
| CN106306314A (zh) * | 2016-10-12 | 2017-01-11 | 肥西久盛食品有限公司 | 一种清咽润喉的魔芋花生糖 |
Non-Patent Citations (2)
| Title |
|---|
| 张仲源等: "《生活窍门速查手册》", 28 February 2013, 上海科学技术文献出版社 * |
| 葛会贤等: "《农畜产品开发指南》", 30 June 2000, 中国农业出版社 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107495374A (zh) * | 2017-09-29 | 2017-12-22 | 杞源堂（宁夏）生物科技有限公司 | 一种含枸杞果粒的富硒西瓜粉口含片及其制备方法 |
| CN109965070A (zh) * | 2017-12-27 | 2019-07-05 | 上海梓惜生物技术有限公司 | 一种枸杞蒲公英压片糖果及其制备方法 |
| CN108391803A (zh) * | 2018-01-12 | 2018-08-14 | 杭州姚生记食品有限公司 | 一种山核桃仁水果粒复合食品及其制备方法 |
| CN109198143A (zh) * | 2018-08-13 | 2019-01-15 | 韩恩珍 | 具有预防和治疗癌症功效的超浓缩生物复合花青素压片糖果及制备方法 |
| CN111035007A (zh) * | 2018-10-11 | 2020-04-21 | 张秀成 | 补虚损保健品组合物及其制备方法和其应用 |
| CN115444063A (zh) * | 2022-08-26 | 2022-12-09 | 衡阳周福记食品有限公司 | 一种护齿棒棒糖的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107094974A (zh) | 一种黑枸杞保健糖果及其制备方法 | |
| CN104017700B (zh) | 一种调和养生酒及其制备方法 | |
| CN103999996A (zh) | 一种保健板栗及其制备方法 | |
| CN103392761B (zh) | 一种虎杖红枣保健面包 | |
| CN103932333A (zh) | 一种神秘果汁饮料及其制备方法 | |
| CN102224891A (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
| KR20140074422A (ko) | 숫누에번데기를 주원료로 한 환(丸) 제품의 제조방법 | |
| CN106343343A (zh) | 一种降三高的多穗柯苦荞组合物及其应用 | |
| CN106070626A (zh) | 酸马奶水果饮料及其制备方法 | |
| CN105767110A (zh) | 一种保健蛋糕及其制备方法 | |
| CN104017699B (zh) | 一种春季调和养生酒及其制备方法 | |
| CN103584105A (zh) | 一种止咳润肺膏及其制备方法 | |
| CN110214902A (zh) | 一种儿童纠正偏食型富硒全营养粉 | |
| KR101834638B1 (ko) | 대추를 주원료로 하는 기능성 다식 제조방법 | |
| KR101731899B1 (ko) | 기관지 기능 개선을 위한 건강보조식품 및 그 제조방법 | |
| CN101715958A (zh) | 一种蜂蜜橄榄膏的制备方法 | |
| CN107319083A (zh) | 一种清咽护喉口腔保健枸杞咀嚼糖果及其制备方法 | |
| CN105087284B (zh) | 一种复方树莓养生酒及其制备方法 | |
| CN104031805B (zh) | 一种秋季调和养生酒及其制备方法 | |
| CN104031806B (zh) | 一种夏季调和养生酒及其制备方法 | |
| CN111529642A (zh) | 一种儿童中药棒棒膏及其制作方法 | |
| KR100815333B1 (ko) | 한약재를 이용한 건강식품 및 그 제조방법 | |
| CN104789401A (zh) | 一种西洋参红葡萄酒的制备方法 | |
| CN108967757A (zh) | 一种红枣生姜浓浆生产工艺 | |
| CN104223201A (zh) | 一种浒苔八宝粥 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170829 |